Obesity and Breast Cancer: A Paradoxical and Controversial Relationship Influenced by Menopausal Status

Otros/as autores/as

Institut Català de la Salut

[García-Estévez L] Breast Cancer Department, MD Anderson Cancer Center, Madrid, Spain. Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. [Cortés J] International Breast Cancer Center (IBCC), Barcelona, Spain. Medical Scientia Innovation Research (MedSIR), Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. [Pérez S, Calvo I, Gallegos I] Breast Cancer Department, MD Anderson Cancer Center, Madrid, Spain. [Moreno-Bueno G] Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. Biochemistry Department, Universidad Autónoma de Madrid (UAM), Instituto de Investigaciones Biomédicas ‘Alberto Sols’ (CSIC-UAM), IdiPaz, & Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. MD Anderson International Foundation, Madrid, Spain

Vall d'Hebron Barcelona Hospital Campus

Fecha de publicación

2022-02-01T13:41:23Z

2022-02-01T13:41:23Z

2021-08-13



Resumen

Mamografia; Menopausa; Obesitat


Mamografía; Menopausia; Obesidad


Mammogram; Menopause; Obesity


Breast cancer is the most common tumor in women worldwide, and an increasing public health concern. Knowledge of both protective and negative risk factors is essential for a better understanding of this heterogenous disease. We undertook a review of the recent literature and evaluated the relationship between obesity mediators and breast cancer development depending on menopausal status. Excess weight is now pandemic and has replaced tobacco as the main lifestyle-related risk factor for premature death. Although the prevalence of obesity/overweight has increased globally over the last 50 years, the potential harm attributable to excess fat has generally been underestimated. The relationship between overweight/obesity, breast cancer and overall risk appears to be highly dependent on menopausal status. Thus, obesity increases the risk of breast cancer in postmenopausal women but, conversely, it appears to be protective in premenopausal women. We evaluate the role of different clinical factors potentially involved in this seemingly contradictory relationship, including estrogen, mammogram density, adipokines, insulin-signaling pathway activation, and inflammatory status. A key focus of this review is to better understand the impact of body mass index and menopausal status on these clinical factors and, hence, provide some clarity into the inter-relationships involved in this controversial issue.


This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Tipo de documento

Artículo


Versión publicada

Lengua

Inglés

Publicado por

Frontiers Media

Documentos relacionados

Frontiers in Oncology;11

https://doi.org/10.3389/fonc.2021.705911

Citación recomendada

Esta citación se ha generado automáticamente.

Derechos

Attribution 4.0 International

http://creativecommons.org/licenses/by/4.0/

Este ítem aparece en la(s) siguiente(s) colección(ones)